Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 3,204 | 2,956 | 3,888 | 3,220 | 2,238 |
| Cost of Goods | 317 | 685 | 524 | 609 | 338 |
| Gross Profit | 2,887 | 2,271 | 3,364 | 2,611 | 1,900 |
| Operating Expenses | 6,578 | 5,594 | 4,503 | 3,780 | 3,865 |
| Operating Income | -3,691 | -3,323 | -1,139 | -1,169 | -1,965 |
| Other Income | 24,536 | 10,059 | 2,263 | 15,237 | 7,467 |
| Pre-tax Income | 20,845 | 6,736 | 1,124 | 14,068 | 5,502 |
| Income Tax | 1,889 | 1,547 | 903 | 1,138 | 1,483 |
| Net Income Continuous | 18,956 | 5,189 | 221 | 12,930 | 4,019 |
| Net Income | $18,956 | $5,189 | $221 | $12,930 | $4,019 |
| EPS Basic Total Ops | 0.13 | 0.04 | 0.00 | 0.09 | 0.03 |
| EPS Basic Continuous Ops | 0.13 | 0.04 | 0.00 | 0.09 | 0.03 |
| EPS Diluted Total Ops | 0.13 | 0.04 | 0.00 | 0.09 | 0.03 |
| EPS Diluted Continuous Ops | 0.13 | 0.04 | 0.00 | 0.09 | 0.03 |
| EBITDA(a) | $-3,172 | $-2,800 | $-637 | $-660 | $-1,501 |